What You Should Know:
Sensos a Sony Semiconductor Israel spin-off, has successfully closed its Series A funding round to further develop a proactive supply chain management solution. The funding was led by Mitsui-backed Magenta Venture Partners, who were joined by JAL Ventures, with the participation of Israel Cargo Logistics, and Sumitomo Corporation.The smart logistics industry that tracks shipments and manages remote inventory is fragmented, relying on partial digital solutions, poor
Read More
Digital Health | News, Analysis, Insights - HIT Consultant
Samsung Galaxy Watch Receives FDA Nod for Sleep Apnea Detection
What You Should Know:
- Samsung's Galaxy Watch has received De Novo authorization from the US Food and Drug Administration (FDA) for its sleep apnea detection feature.
- This marks a significant step forward in wearable technology, making it the first of its kind to be approved by the FDA for detecting potential sleep apnea.
Defining Sleep Apnea
Sleep apnea is a common and chronic sleep disorder where breathing repeatedly stops and starts during sleep. This can lead to disruptions in
Read More
CareSource Becomes LP with Boomerang Ventures for Co-Investment Opportunities
What You Should Know:
- Boomerang Ventures, an early-stage venture studio and venture capital fund focused on connected health solutions, has announced a strategic partnership with CareSource, a nationally recognized non-profit managed care organization.
- The strategic collaboration marks a significant step towards advancing healthcare access, quality, and equity.
Partnership Benefits
CareSource becomes a Limited Partner: This investment empowers Boomerang to expand its reach
Read More
Medicare Expands Coverage for Eversense E3 CGM System, Offering More Options for Diabetes Management
What You Should Know:
- Medicare has significantly expanded access to the Eversense E3 continuous glucose monitoring (CGM) System, a long-lasting and implantable option that offers several advantages over traditional CGMs.
- Medicare has significantly expanded access to the Eversense E3 CGM System, the longest-lasting continuous glucose monitor available, with the implementation of Local Coverage Determinations providing access to implantable CGM for basal-only patients, by the first three
Read More
Ambient AI Scribes Reduce Clinician Burden, TPMG Pilot Reveals
What You Should Know:
- Ambient artificial intelligence (AI) scribes show early promise in reducing clinicians’ burden, according to a recent The Permanente Medical Group (TPMG) pilot.
- Published in NEJM Catalyst, TPMG recently implemented ambient AI scribes for 10,000 physicians and staff.
Ambient AI Scribes
Ambient AI scribes represent a cutting-edge technological solution designed to mitigate the documentation workload faced by physicians. By employing machine learning algorithms
Read More
Calibrate Appoints Rob MacNaughton as New CEO
What You Should Know:
- Calibrate, the leading clinician-guided and value-based obesity treatment program, today announced the appointment of Rob MacNaughton as its new Chief Executive Officer.
- Calibrate's strategic direction under MacNaughton's leadership and the OptumRx partnership position the company for significant growth and a positive impact on both individual and corporate healthcare landscapes.
MacNaughton Bio/Background
MacNaughton boasts a distinguished track record in
Read More
CentralReach Acquires Social-Emotional Learning Provider SILAS to Expand Education Suite
What You Should Know:
- CentralReach, a leading provider of Autism and Intellectual and Developmental Disabilities (IDD) software, announced the acquisition of SILAS, a company specializing in social and emotional learning (SEL) and behavior solutions for PreK-12 education.
- By combining SILAS's expertise in SEL and behavior with CentralReach's existing strengths in Autism and IDD support, the company is well-positioned to empower schools and educators in nurturing well-rounded and
Read More
Unlearn Raises $50M to Accelerate AI-Powered Clinical Trials with Digital Twins
What You Should Know:
- Unlearn®, a leading AI company using digital twins to revolutionize clinical trials, announced today a $50M Series C funding round led by Altimeter Capital. This investment, bringing Unlearn's total funding to over $130M, will fuel its mission to eliminate trial and error in medicine through faster, smaller, and more ethical clinical trials.
- Unlearn collaborates with pharmaceutical companies, biotechs, and academic institutions to optimize and streamline clinical
Read More
Solera Health’s CEO Steps Down, Assumes Chairman Role
What You Should Know:
- Solera Health, a leading platform connecting people with effective health solutions, announced today that Mary Langowski, is stepping down as Chief Executive Officer and transitioning to the role of Chairman of the Board. An interim CEO will be named soon.
-The Board expressed its deep appreciation to Langowski for her transformative leadership. Board member Matt Downs, stepping down as Chair but remaining a voting member, praised her impact and expressed
Read More
Nabla Appoints Dr. Ed Lee as Chief Medical Officer
What You Should Know:
- Nabla, the leading ambient AI assistant for healthcare professionals, announced the appointment of Dr. Ed Lee, MD, MPH, as Chief Medical Officer.
- As Chief Medical Officer, Dr. Lee will shape Nabla's clinical strategy and product roadmap. He will contribute to feature enhancements, advocate for Nabla at industry events, and provide valuable insights on clinical informatics trends.
Dr. Lee Bio/Background
Dr. Lee joins Nabla with over 20 years of experience as
Read More
